Takehiro Okabayashi

Dr. Takehiro Okabayashi

Department of Gastroenterological Surgery, Kochi Health Sciences Center, Kochi 783-8505, Japan
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in World Journal of Gastroenterology
Verified
Journal Article
Open access
Takehiro OkabayashiTakehiro Okabayashi
Takehiro Okabayashi
YSYasuo Shima
Yasuo Shima
TSTatsuaki Sumiyoshi
Tatsuaki Sumiyoshi
AKAkihito Kozuki
Akihito Kozuki
SISatoshi Ito
Satoshi Ito
KHKazuhiro Hanazaki
Kazuhiro Hanazaki
Insulinomas, the most common cause of hypoglycemia related to endogenous hyperinsulinism, occur in 1-4 people per million of the general population. Common autonomic symptoms of insulinoma include diaphroresis, tremor, and palpitations, whereas neuroglycopenenic symptoms include confusion, behavioural changes, personality changes, visual disturbances, seizure, and coma. Diagnosis of suspected cases is based on standard endocrine tests, especially the prolonged fasting test. Non-invasive imaging procedures, such as computed tomography and magnetic resonance imaging, are used when a diagnosis of insulinoma has been made to localize the source of pathological insulin secretion. Invasive modalities, such as endoscopic ultrasonography and arterial stimulation venous sampling, are highly accurate in the preoperative localization of insulinomas and have frequently been shown to be superior to non-invasive localization techniques. The range of techniques available for the localization of insulinomas means that blind resection can be avoided. Intraoperative manual palpation of the pancreas by an experienced surgeon and intraoperative ultrasonography are both sensitive methods with which to finalize the location of insulinomas. A high proportion of patients with insulinomas can be cured with surgery. In patients with malignant insulinomas, an aggressive medical approach, including extended pancreatic resection, liver resection, liver transplantation, chemoembolization, or radiofrequency ablation, is recommended to improve both survival and quality of life. In patients with unresectable or uncontrollable insulinomas, such as malignant insulinoma of the pancreas, several techniques should be considered, including administration of ocreotide and/or continuous glucose monitoring, to prevent hypoglycemic episodes and to improve quality of life.

26 October 2023 in Annals of Surgery
Verified
Journal Article
Open access
Ryota MatsuiRyota Matsui
Ryota Matsui
MSMasano Sagawa
Masano Sagawa
ASAkihiko Sano
Akihiko Sano
MSMakoto Sakai
Makoto Sakai
SHShin-ichiro Hiraoka
Shin-ichiro Hiraoka
JKJoji Kotani
Joji Kotani
Objective: To clarify whether perioperative immunonutrition is effective in adult patients with or without malnutrition undergoing elective surgery for head and neck (HAN) or gastrointestinal (GI) cancers. Background: It is important to avoid postoperative complications in patients with cancer as they can compromise clinical outcomes. There is no consensus on the efficacy of perioperative immunonutrition in patients with or without malnutrition undergoing HAN or GI cancer surgery. Materials and Methods: We searched MEDLINE (PubMed), MEDLINE (OVID), EMBASE, Cochrane Central Register of Controlled Trials, Web of Science Core Selection, and Emcare from 1981 to 2022 using search terms related to immunonutrition and HAN or GI cancer. We included randomized controlled trials. Intervention was defined as immunonutritional therapy including arginine, n-3 omega fatty acids, or glutamine during the perioperative period. The control was defined as standard nutritional therapy. The primary outcomes were total postoperative and infectious complications, defined as events with a Clavien–Dindo classification grade ≥ II that occurred within 30 days after surgery. Results: Of the 4825 patients from 48 included studies, 19 had upper GI cancer, 9 had lower, and 8 had mixed cancer, whereas 12 had HAN cancers. Immunonutrition reduced the total postoperative complications (relative risk ratio: 0.78; 95% CI, 0.66–0.93; certainty of evidence: high) and infectious complications (relative risk ratio: 0.71; 95% CI, 0.61–0.82; certainty of evidence: high) compared with standard nutritional therapy. Conclusions: Nutritional intervention with perioperative immunonutrition in patients with HAN and GI cancers significantly reduced total postoperative complications and infectious complications.

28 December 2017 in Surgery Today
Verified
Journal Article
Closed access
PDF file
KSKenta Sui
Kenta Sui
Takehiro OkabayashiTakehiro Okabayashi
Takehiro Okabayashi
JIJun Iwata
Jun Iwata
SMSojiro Morita
Sojiro Morita
TSTatsuaki Sumiyoshi
Tatsuaki Sumiyoshi
YSYasuhiro Shimada
Yasuhiro Shimada

22 December 2017 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
Takehiro OkabayashiTakehiro Okabayashi
Takehiro Okabayashi
YSYasuo Shima
Yasuo Shima
TSTatsuaki Sumiyoshi
Tatsuaki Sumiyoshi
KSKenta Sui
Kenta Sui
JIJun Iwata
Jun Iwata
YSYasuhiro Shimada
Yasuhiro Shimada

1 December 2017 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
Takehiro OkabayashiTakehiro Okabayashi
Takehiro Okabayashi
YSYasuo Shima
Yasuo Shima
SMSojiro Morita
Sojiro Morita
YSYasuhiro Shimada
Yasuhiro Shimada
TSTatsuaki Sumiyoshi
Tatsuaki Sumiyoshi
TITatsuo Iiyama
Tatsuo Iiyama
The prediction of postoperative liver function remains a largely subjective practice based on CT volumetric analysis. However, future liver volume after a hepatectomy is not the only factor that contributes to postoperative liver function and outcomes. In this prospective trial, 185 consecutive patients who underwent liver operations between 2014 and 2015 were studied. Volumetric and functional rates of remnant liver were measured using technetium 99m-galactosyl human serum albumin single-photon emission computed tomography/CT fusion imaging to evaluate post-hepatectomy remnant liver function. Remnant indocyanine green clearance rate using galactosyl (KGSA) (KGSA × functional rate) was used to predict future remnant liver function. Hepatectomy was considered safe for patients with remnant KGSA values ≥0.05, and the primary end point was to determine the accuracy and reliability of this criteria. The prediction of the 90-day major complication and mortality rates was assessed. Median hospital stay was 9 days and median ICU stay was 1 day, with only 1 in-hospital death (90-day mortality rate 0.5%). Overall morbidity rate evaluated according to the Clavien-Dindo classification was 9%. For post-hepatectomy liver failure definitions, the International Study Group of Liver Surgery definition was fulfilled in 14 patients (8%), with the majority being grade B (50%), compared with 2 patients (1%) fulfilling the "50-50" criteria, and 0 patients (0%) fulfilling the PeakBili >7 criteria. Results of this study showed that remnant KGSA provided information that allowed us to predict remnant liver function. This information will be important for surgeons when deciding on a treatment plan for patients with liver diseases. (ClinicalTrials.gov ID: NCT02013895).

26 October 2013 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
Takehiro OkabayashiTakehiro Okabayashi
Takehiro Okabayashi
YSYasuo Shima
Yasuo Shima
JIJun Iwata
Jun Iwata
TITatsuo Iiyama
Tatsuo Iiyama
TSTatsuaki Sumiyoshi
Tatsuaki Sumiyoshi
MMMasanori Morita
Masanori Morita